DMAAU · Insider Trading
Drugs Made In America Acquisition Corp. Units
Every open-market purchase and sale reported by DMAAU officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-18 | Drugs Made In America Acquisition LLC | 10%+ Owner | Buy | +30,000 | — |
| 2025-02-18 | Lynn Stockwell | CEO and Exe. Chair of Board | Buy | +30,000 | — |
| 2025-02-04 | Drugs Made In America Acquisition LLC | 10%+ Owner | MIXED | −5,698,363 | — |
| 2025-02-04 | Lynn Stockwell | CEO and Executive COB | MIXED | −5,698,363 | — |
| 2025-02-03 | Myron W. Shulgan | Director | J | +100,000 | — |
| 2025-02-03 | Sridhar G. Prasad | Director | J | +100,000 | — |
| 2025-02-03 | Glenn C. Worman | CFO | J | +100,000 | — |
| 2025-02-03 | Catherine Do | Director | J | +100,000 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Lynn Stockwell | CEO and Exe. Chair of Board | 4,188,780 | $47.33M |
| Drugs Made In America Acquisition LLC | 10%+ Owner | 4,188,780 | $47.33M |
| Glenn C. Worman | CFO | 100,000 | $1.13M |
| Sridhar G. Prasad | Director | 100,000 | $1.13M |
| Myron W. Shulgan | Director | 100,000 | $1.13M |
| Catherine Do | Director | 100,000 | $1.13M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DMAAU quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.